Market Research Reports

All Reports Home

Categories

Countries

Pharmaceuticals Reports

United States Breast Cancer Therapeutics Market, By Therapy {Chemotherapy (Anthracyclines, Taxanes, Antimetabolites, and Others), Hormone Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Others), Immunotherapy, Targeted Therapy (Monoclonal Antibodies, Tyrosine Kinase Inhibitor, Herceptin, and Others), and Others}, By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), and By Region, Competition, Forecast & Opportunities, 2028

Growing cases of breast cancer are expected to drive the growth of the market during the forecast period.Read More

Canada Telemedicine Market By Component (Services & Software, Hardware), By Deployment Mode (Cloud, On-Premises), By Type (Tele-Hospitals, mHealth, and Tele-Homes), By Application (Tele-Psychiatry, General Consultations, Tele-Radiology, Tele-Pathology, and Others), By End User (Patients, Provider, and Payers), By Region, Competition, Forecast and Opportunities, 2028F

The growing demand for expanding healthcare access is expected to drive the growth of Canada telemedicine market in the forecast period, 2024-2028.Read More

Canada Generic Drugs Market By Type (Small Molecule Generics, Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, and Others), By Form (Tablet, Capsule, Injection, and Others), By Source (In House, Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and By Region, Competition, Forecast, and Opportunities, 2028

The increasing demand for low-cost medicines is expected to drive the growth of the Canada generic drugs market during the forecast period.Read More

Canada Regenerative Medicine Market By Type (Cell Therapies, Gene Therapies, Progenitor & Stem Cell Therapies, and Tissue Engineered Products), By Application (Musculoskeletal Disorders, Wound Care, Oncology, Ophthalmology, Neurology, Dermatology, and Others), By End User (Academic v/s Commercial), and By Region, Competition, Forecast & Opportunities, 2018-2028F

The increasing prevalence of chronic ailments is expected to drive the growth of the Canada regenerative medicine market during the forecast period.Read More

Canada Cell Therapy Manufacturing Market By Therapy (T-Cell Therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies), By Source of Cell (Autologous v/s Allogenic), By Source (In-House v/s Contract Manufacturing), By Application (Oncology, Cardiovascular Diseases, Orthopedic Diseases, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), and By Region, Competition, Forecast & Opportunities, 2018-2028

Canada cell therapy manufacturing market is expected to grow during the forecast period due to increasing prevalence of chronic diseases.Read More

United States Ovarian Cancer Therapeutics Market, By Treatment (Chemotherapy, Radiation Therapy, Immunotherapy, Hormonal Therapy, and Others), By Tumor Type (Epithelial Ovarian Cancer, Ovarian Low Malignant Potential Tumor, Germ Cell Tumor, and Sex Cord-Stromal Tumor), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition Forecast & Opportunities, 2028

Increasing prevalence of ovarian cancer is expected to drive the growth of the United States Ovarian Cancer Therapeutics Market in the forecast period, 2024-2028.Read More

Turkey Over-The-Counter Drugs Market- By Product Type (Cough & Cold Drugs, Analgesics Drugs, Dermatology Drugs, Gastrointestinal Drugs, Vitamins, Minerals, and Supplements (VMS), Ophthalmic Drugs, Others), By Route of Drug Administration (Oral, Parenteral, Topical, Others), By Dosage Form (Tablets, Capsules, Liquids & Solutions, Cream/Lotion/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy) By Region, Competition, Forecast, and Opportunities, 2028

Increasing population, rising healthcare expenditure, and growing awareness of self-medication are factors driving the growth of the market in the forecast Read More

Malaysia Generic Drugs Market By Type (Small Molecule Generics, Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, and Others), By Drug Delivery (Oral, Topical, Parenteral, and Others), By Form (Tablet, Capsule, Injection, and Others), By Source (In House, Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), By Region, Competition, Forecast and Opportunities, 2028

Growing prevalence of chronic diseases and rise in geriatric population of the country will drive the generic drug market in the forecast period, 2018-2028F.Read More

Exosome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Exosome Type (Natural v/s Hybrid), By Source (Mesenchymal Stem Cells, Blood, Body Fluids, Others), By Therapy (Immunotherapy, Chemotherapy, Gene Therapy), By Application (Metabolic Disorders, Oncology, Cardiac Disorders, Neurology, Others), By End User (Hospitals & Clinics, Academics & Research Institutions, Others), By Region

Increasing molecular diagnosis and the emerging role of exosomes in the treatment of chronic diseases to drive the global exosome therapeutics market in the Read More

Israel Generic Drugs Market, By Type (Pure Generic Drugs, Branded Generic Drugs), By Application (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), By Drug Delivery (Oral, Injectables, Dermal/Topical, and Inhalers), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies), By Region, Competition, Forecast & Opportunities, 2028

Rapid technological advancements and the rising case of chronic and infectious diseases are expected to drive the Israel generic drugs market during the forecast Read More

Canada Cancer Diagnostics Market, By Product (Consumables, Instruments), Technology (IVD Testing, Imaging, and Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, and Others), End User (Hospitals & Clinics, Diagnostic Laboratories, and Others), By Region Competition Forecast and Opportunities, 2028

The increasing number of diagnostic centers is expected to drive the Canada cancer diagnostics market during the forecast period.Read More

Egypt Anti-Hypertensive Drugs Market, By Therapeutic Class (Diuretics, ACE inhibitors, Angiotensin Receptor Blockers (ARBs), Calcium Channel Blockers, Beta Adrenergic Blockers, Renin Inhibitors, Vasodilators, Others), By Type (Primary Hypertension, Secondary Hypertension), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce Websites & Online Drug Stores), By Region, Competition Forecast & Opportunities, 2028

Growing prevalence of hypertension is expected to drive the growth of the Egypt anti-hypertensive drugs market during the forecast period, 2024-2028.Read More

Canada Pharmaceutical Market by Drug Type (Generic and Branded drugs), By Product Type (Over-The-Counter Drugs, Prescription Drugs), By Application (Cardiovascular, Oncology, Metabolic Disorder, Musculoskeletal, Anti-infective, and Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region and Competition, Forecast & Opportunities, 2018-2028F

The growing aging population is expected to drive the growth of Canada Pharmaceutical market in the forecast period, 2024-2028. Read More

Egypt Personalized Nutrition Market, By Dosage Form (Tablets, Capsule, Powders, Liquids, Others), By Product Type (Dietary Supplements and Nutraceuticals, Functional Food, Functional Beverage, Digitalized DNA-based Diet, Sports Nutrigenomics, Others), By Tool Type (Genetic test kits, Food labels, Interactive apps, Portable gadgets, Wearable, Others), By Application (Standard Supplements, Disease Based, Additional Supplements, Medicinal Supplements, Sports Nutrition) By Region, Competition, Forecast & Opportunities, 2028

Increasing number of people with chronic diseases such as diabetes, hypertension, and obesity is expected to drive the growth of the Egypt personalized nutrition Read More

Canada Clinical Biomarkers Market by Product (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), By Services (Genomic Biomarker Service, Tissue Biomarker Service, Cell Service, Proteomics Service), By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Immunohistochemistry, Enzyme-Linked Immunosorbent Assay, Others), By Clinical Area (Cancer Biomarker, Cardiac Biomarker, Neurological Biomarker, Infectious Disease Biomarker, Others), By Application (Translational Research v/s Clinical Diagnostics), By End User (Biotechnology & Pharmaceutical Companies, Diagnostic Centers, Academic & Research Institutions, Others), By Region and Competition, Forecast & Opportunities, 2018-2028

The rising prevalence of cancer is expected to drive the growth of the Canada clinical biomarkers market during the forecast period, 2024-2028.Read More

Israel Over the Counter (OTC) Drugs Market By Product Type (Cough, Cold and Flu, Vitamins, Mineral, & Supplements (VMS), Analgesics, Gastrointestinal Products, Dermatology Products, Others), By Route of Administration (Oral, Topical, Parenteral, Others), By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Pharmacies, Others), By Region, Competition, Forecast and Opportunities, 2028 2028

Increasing trend of self-medication, affordability of over-the-counter drugs is expected to drive the Israel Over the Counter (OTC) Drugs market.Read More

Canada Osteoarthritis Therapeutics Market By Anatomy (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Small Joint Osteoarthritis), By Drug Type (Visco supplementation Agents, Non-steroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region and Competition, Forecast & Opportunities, 2018-2028F

Canada Osteoarthritis Therapeutics Market growth is driven by the increasing prevalence of Osteoarthritis in the forecast period 2024-2028.Read More

Israel Anti-Hypertensive Drugs Market, By Therapeutic Class (Diuretics, ACE inhibitors, Angiotensin Receptor Blockers (ARBs), Calcium Channel Blockers, Beta Adrenergic Blockers, Renin Inhibitors, Vasodilators, Others), By Type (Primary Hypertension, Secondary Hypertension), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce Websites & Online Drug Stores), By Region, Competition Forecast & Opportunities, 2028

Rising incidence of hypertension across the country is expected to drive the growth of the market in the forecast period 2024 - 2028.Read More

Israel Gynecology Drugs Market By Therapeutics (Non-Hormonal Therapy vs. Hormonal Therapy), By Indication (Contraception, Gynecology Infections, Female Infertility, Postmenopausal disorders, Polycystic Ovary Syndrome, Osteoporosis, Gynecology Cancer, Endometriosis, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition, Forecast and Opportunities, 2028

Increasing prevalence of gynecological disorders and availability of targeted therapies for gynecological cancers are expected to drive the Israel gynecology Read More

Egypt Nutraceuticals Market, By Product Type (Dietary Supplements, Functional Foods, Functional Beverages), By Form (Tablets, Capsules, Powder, Liquid, Others), By Source (Animal, Plant, Microbial), By Distribution Channel (Specialty Stores, Online, Pharmacies, Hypermarkets/Supermarkets), By Region, Competition Forecast & Opportunities, 2028

Increasing instances of lifestyle-related disorders are expected to drive the growth of the market in the forecast period 2024-2028.Read More

Prev    Page 25 of 30 Next